Insider Selling: Intuitive Surgical (NASDAQ:ISRG) Director Sells $236,730.00 in Stock

Intuitive Surgical, Inc. (NASDAQ:ISRG) Director Amy Ladd sold 500 shares of the business’s stock in a transaction that occurred on Tuesday, April 28th. The shares were sold at an average price of $473.46, for a total value of $236,730.00. Following the transaction, the director owned 239 shares of the company’s stock, valued at $113,156.94. This trade represents a 67.66% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.

Intuitive Surgical Price Performance

Shares of NASDAQ:ISRG opened at $457.78 on Friday. Intuitive Surgical, Inc. has a 1 year low of $427.84 and a 1 year high of $603.88. The business has a 50 day simple moving average of $474.86 and a two-hundred day simple moving average of $515.98. The firm has a market capitalization of $162.13 billion, a PE ratio of 55.49, a price-to-earnings-growth ratio of 3.67 and a beta of 1.51.

Intuitive Surgical (NASDAQ:ISRG) last announced its quarterly earnings results on Tuesday, April 21st. The medical equipment provider reported $2.50 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $2.08 by $0.42. The firm had revenue of $2.77 billion during the quarter, compared to analyst estimates of $2.62 billion. Intuitive Surgical had a return on equity of 15.98% and a net margin of 28.15%.Intuitive Surgical’s quarterly revenue was up 23.0% on a year-over-year basis. During the same quarter in the previous year, the business earned $1.81 earnings per share. Equities research analysts expect that Intuitive Surgical, Inc. will post 8.53 EPS for the current fiscal year.

Analyst Upgrades and Downgrades

A number of brokerages recently issued reports on ISRG. Citigroup upgraded Intuitive Surgical from a “neutral” rating to a “buy” rating and set a $590.00 price target for the company in a report on Wednesday, March 11th. HSBC lowered their price target on Intuitive Surgical from $653.00 to $604.00 and set a “buy” rating for the company in a report on Wednesday, April 22nd. Leerink Partners lowered their price target on Intuitive Surgical from $622.00 to $573.00 and set an “outperform” rating for the company in a report on Wednesday, April 22nd. Evercore lowered their price target on Intuitive Surgical from $550.00 to $480.00 and set a “neutral” rating for the company in a report on Monday, April 6th. Finally, UBS Group lowered their price target on Intuitive Surgical from $570.00 to $550.00 and set a “neutral” rating for the company in a report on Tuesday, March 17th. Eighteen research analysts have rated the stock with a Buy rating, seven have given a Hold rating and one has issued a Sell rating to the stock. According to MarketBeat.com, the stock has an average rating of “Moderate Buy” and an average price target of $581.91.

Institutional Trading of Intuitive Surgical

A number of hedge funds have recently bought and sold shares of the stock. Global Assets Advisory LLC purchased a new stake in Intuitive Surgical during the first quarter worth $534,000. Trifecta Capital Advisors LLC lifted its holdings in Intuitive Surgical by 2.0% during the first quarter. Trifecta Capital Advisors LLC now owns 14,746 shares of the medical equipment provider’s stock worth $6,798,000 after buying an additional 285 shares during the period. Anchor Investment Management LLC lifted its holdings in Intuitive Surgical by 4.2% during the first quarter. Anchor Investment Management LLC now owns 6,599 shares of the medical equipment provider’s stock worth $3,042,000 after buying an additional 269 shares during the period. ARQ Wealth Advisors LLC purchased a new stake in Intuitive Surgical during the first quarter worth $505,000. Finally, Diversify Wealth Management LLC lifted its holdings in Intuitive Surgical by 127.5% during the first quarter. Diversify Wealth Management LLC now owns 23,038 shares of the medical equipment provider’s stock worth $10,456,000 after buying an additional 12,912 shares during the period. Hedge funds and other institutional investors own 83.64% of the company’s stock.

About Intuitive Surgical

Intuitive Surgical, founded in 1995 and headquartered in Sunnyvale, California, is a medical technology company focused on the design, manufacture and service of robotic-assisted surgical systems. The company is best known for its da Vinci surgical systems, which enable minimally invasive procedures by translating a surgeon’s hand movements into finer, scaled motions of small instruments inside the patient. Intuitive’s business centers on supplying hospitals and surgical centers with systems, instruments and related technologies that aim to improve precision, visualization and control in the operating room.

In addition to its core surgical platforms, Intuitive markets a portfolio of reusable and disposable instruments, accessories, and proprietary software, and provides training, servicing and clinical support to its customers.